In one paragraphArticle in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Sylvia ValdezateReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0002-3931-2162 Mónica ValienteReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
Gema CarrascoReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0003-0215-6503 María J Medina-PascualReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
María Isabel HurtadoReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
Noelia GarridoReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
Carmen ParadasCSUR/ERN de Enfermedades Neuromusculares, UGC Neurología, Hospital Universitario Virgen del Rocío/IBiS, 41013 Sevilla, Spain.
José Ramón Hernández-BelloSección Epidemiología, Servicio de Salud, Delegación Territorial de Salud y Consumo en Sevilla, 41018 Sevilla, Spain.
Pilar VillalónReference and Research Laboratory for Taxonomy, National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0003-3026-2178 Funding
Agencia Estatal de Investigación PID2021127477OBI00/MPY-302/22Ministerio de Ciencia, Innovación y Universidades PID2021127477OBI00/MPY-302/22
6 · The paper itselfAbstract
The neurotoxin BoNT/B2 is the predominant
Indexed as
Botulinum Toxins, Type ABotulismHumansMaleMiddle AgedMultilocus Sequence TypingPhylogenySpainBotulinum Toxins, Type ABoNT/A(B)botulinum neurotoxinClostridium parabotulinumfood-borne botulism
Identifiers
PMID41003494
PMCPMC12473986
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390